Dalal, Deepika and Dahiya, Kiran and Gupta, Keerti (2020) Ischemia Modified Albumin and Type 2 Diabetes Mellitus. In: Current Topics in Medicine and Medical Research Vol. 4. B P International, pp. 1-6. ISBN 978-93-90206-82-7
Full text not available from this repository.Abstract
Human serum albumin is the circulating protein which is synthesized in liver. It undergoes various
modifications in its properties in type II diabetic patients. There is alteration in N-terminal which leads
to its reduced binding to other metals and is known as Ischemia Modified Albumin which can be
measured by the albumin cobalt binding assay which is based on the fact that IMA has reduced
capacity to bind cobalt as compared to Albumin. IMA is a proven marker for cardiovascular diseases.
It produces reactive oxygen species and is also a common risk factor for cardiovascular events.
Measuring its levels in type II Diabetes Mellitus may help to predict the status of complications
associated with it.
| Item Type: | Book Section |
|---|---|
| Subjects: | Eurolib Press > Medical Science |
| Depositing User: | Managing Editor |
| Date Deposited: | 09 Nov 2023 05:38 |
| Last Modified: | 09 Nov 2023 05:38 |
| URI: | http://info.submit4journal.com/id/eprint/2946 |
Actions (login required)
- View Item